These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9703430)

  • 21. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.
    Cao AY; Jin W; Shi PC; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2010 Jan; 119(2):295-303. PubMed ID: 19238535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla.
    Patrikidou A; Bennett J; Abou-Sleiman P; Delhanty JD; Harris M
    Oral Oncol; 2002 Jun; 38(4):383-90. PubMed ID: 12076704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
    Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing.
    Zampiga V; Danesi R; Tedaldi G; Tebaldi M; Cangini I; Pirini F; Pittureri C; Amaducci E; Guidi L; Faedi M; Amadori D; Falcini F; Calistri D
    Int J Biol Markers; 2016 Dec; 31(4):e461-e465. PubMed ID: 27516001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
    J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome.
    Macaulay S; Goodyear QC; Kruger M; Chen W; Essop F; Krause A
    Fam Cancer; 2018 Oct; 17(4):607-613. PubMed ID: 29392648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
    Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.
    Wong P; Verselis SJ; Garber JE; Schneider K; DiGianni L; Stockwell DH; Li FP; Syngal S
    Gastroenterology; 2006 Jan; 130(1):73-9. PubMed ID: 16401470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
    Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
    Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23.
    Bachinski LL; Olufemi SE; Zhou X; Wu CC; Yip L; Shete S; Lozano G; Amos CI; Strong LC; Krahe R
    Cancer Res; 2005 Jan; 65(2):427-31. PubMed ID: 15695383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2.
    Huusko P; Castrén K; Launonen V; Soini Y; Pääkkönen K; Leisti J; Vähäkangas K; Winqvist R
    Cancer Genet Cytogenet; 1999 Jul; 112(1):9-14. PubMed ID: 10432928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A method for detection of germinal mutations in the p53 tumor suppressor gene].
    Sedlácek Z; Kríz V; Seemanová E; Vlcek C; Maríková T; Mares J; Goetz P
    Cas Lek Cesk; 1996 Dec; 135(23):762-7. PubMed ID: 9005123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.
    van Hest LP; Ruijs MW; Wagner A; van der Meer CA; Verhoef S; van't Veer LJ; Meijers-Heijboer H
    Fam Cancer; 2007; 6(3):311-6. PubMed ID: 17318340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
    Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen LA; Blomqvist C; Aittomäki K; Nevanlinna H
    Cancer Res; 2001 Aug; 61(15):5718-22. PubMed ID: 11479205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.